C
Cezary Szczylik
Researcher at Medical University of Warsaw
Publications - 291
Citations - 30393
Cezary Szczylik is an academic researcher from Medical University of Warsaw. The author has contributed to research in topics: Renal cell carcinoma & Cancer. The author has an hindex of 49, co-authored 274 publications receiving 27380 citations. Previous affiliations of Cezary Szczylik include Military Medical Academy & Cora.
Papers
More filters
Journal ArticleDOI
Bisphosphonates and vascular endothelial growth factor-targeted drugs in the treatment of patients with renal cell carcinoma metastatic to bone.
Eduard Vrdoljak,Brian I. Rini,Manuela Schmidinger,Tomislav Omrčen,Laszlo Torday,Cezary Szczylik,Avishay Sella +6 more
TL;DR: There is evidence that the presence of bone metastases in m-ccRCC patients has a significant and clinically relevant negative impact on survival and potentially on the outcome of VEGF-targeted therapy.
Journal ArticleDOI
Development of extracellular matrix supported 3D culture of renal cancer cells and renal cancer stem cells.
Kamila Maliszewska-Olejniczak,Klaudia Brodaczewska,Zofia F. Bielecka,Wojciech Solarek,Anna Kornakiewicz,Cezary Szczylik,Camillo Porta,Anna M. Czarnecka +7 more
TL;DR: A bio-mimic 3D RCC cell culture model with specific low-serum and xeno-free media that promote R CC cell viability and stem-like phenotype according to the tested genes encoding stemness factors is proposed.
Journal ArticleDOI
Optimizing treatment for patients with metastatic renal cell carcinoma in the central and Eastern European region
Eduard Vrdoljak,Tudor Eliade Ciuleanu,G Kharkevich,Jozef Mardiak,Michal Mego,Peeter Padrik,Luboš Petruželka,Gunta Purkalne,Yaroslav Shparyk,Breda Skrbinc,Cezary Szczylik,Laszlo Torday +11 more
TL;DR: This review discusses the unique challenges faced by the aforementioned Eastern European countries in the treatment of metastatic renal cell cancer in an attempt to assist health-care providers in providing the best care possible for their European patients.
Journal ArticleDOI
Ovarian cancer as a genetic disease.
Agnieszka Lech,Teodora Daneva,Shina Pashova,Hristo Gagov,Robert Crayton,Wojciech Kukwa,Anna M. Czarnecka,Cezary Szczylik +7 more
TL;DR: Some genetic factors involved in the disruption of certain signaling pathways responsible for ovarian tumor transformation and development contribute to accurate diagnostics, treatment and prognosis in ovarian cancer.
Journal ArticleDOI
Colorectal cancer in the course of familial adenomatous polyposis syndrome ("de novo" pathogenic mutation of APC gene): case report, review of the literature and genetic commentary.
TL;DR: An atypical case of CRC is reported in a patient with FAP caused by 2797-2800delAACA mutation of the APC gene, which is the most effective method of CRC prevention.